WHO Pre-Qualifies Vaccine Developed by China
The World Health Organization has pre-qualified a vaccine being developed by China. The SA 14-14-2 vaccine could help in treating Japanese encephalitis as deadly fever that affects millions of children in developing countries and is one of the causes on viral neurological disability and disease in Asia.
The pre-qualification of the vaccine show that future in the plans of protecting children in developing countries in contracting the disease along with the availability of the vaccine as China produces its vaccine up to the organization’s standards. This move will also allow the United Nations procurement agencies to purchase the vaccines and to decide whether to endorse the vaccine quality to countries that doubts the vaccines reliability.
The SA 14-14-2 vaccine will have fewer side effects compared to other vaccines for the Japanese encephalitis making it safer for children. The disease is carried by mosquitoes and is endemic in a majority of regions in Western Pacific and Southeast Asia.
Used in China since 1988 more than 600 million vaccines have been administered to children and by 2008 less than 5,000 cases of infections have been reported.